Company would like to inform the Stock Exchange of Thailand (the “SET”) material matters resolved in the meeting as follows: 1. Approve to propose to the shareholders’ meeting to consider and approve the

September 2017 Subject: Notification of the Board of Directors No.8/2017 and the date of the Extraordinary General Meeting of Shareholders No. 1/2017 (Amended) To: The President The Stock Exchange of Thailand

investment on assets (Revision 2) Attention: Directors and Managers The Stock Exchange of Thailand Attachment: 1. Information on the investment on assets 2. F53-4 form 3. Details on the issuance of warrants to

quarter of 2021 To The President The Stock Exchange of Thailand We, Zen Corporation Group Public Company Limited (“the company”), are pleased to provide you our management discussion and analysis for the

No. ADD 25/2022 9 August 2022 Subject: Management discussion and analysis for the performance for the six-month period ended 30 June 2022 To: President The Stock Exchange of Thailand AddTech Hub

Microsoft Word - ACE MDA Q3 23 - EN_R3 1 No. ACE-ACC-4/2023 14 November 2023 Subject Management Discussion and Analysis for the period ended 30 September 2023 To President The Stock Exchange of

28 April 2020 At: ACC/HO 011/63 Re: Management Discussion and Analysis for the Quarter of 1/2020 To: President The Stock Exchange of Thailand Following the Coronavirus 2019 (COVID-19) pandemic and

Carnival Magic Project, and compensation for design and construction to related person. (Update) To: Managing Director The Stock Exchange of Thailand Reference: 1. Capital Increase Report Form (F53-4) 2

27 October 2020 At: ACC/HO 019/63 Re: Management Discussion and Analysis for the Quarter of 3/2020 To: President The Stock Exchange of Thailand During the third quarter of 2020 the Coronavirus 2019

August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries